Identifying cancer driver mutations is essential to understand disease biology and devise effective therapies, but remains a complex endeavor. A focused analytical approach is now presented that defines driver mutations affecting ubiquitin-mediated proteolysis through machine learning and mining of cancer multi-omics data.
References
Cheng, F., Liang, H., Butte, A. J., Eng, C. & Nussinov, R. Pharmacol. Rev. 71, 1–19 (2019).
Martincorena, I. & Campbell, P. J. Science 349, 1483–1489 (2015).
Bailey, M. H. et al. Cell 173, 371–385.e18 (2018).
Ng, P. K. et al. Cancer Cell 33, 450–462.e10 (2018).
Martínez-Jiménez, F., Muiños, F., López-Arribillaga, E., Lopez-Bigas, N. & Gonzalez-Perez, A. Nat. Cancer https://doi.org/10.1038/s43018-019-0001-2 (2019).
Laney, J. D. & Hochstrasser, M. Cell 97, 427–430 (1999).
Meszaros, B., Kumar, M., Gibson, T. J., Uyar, B. & Dosztanyi, Z. Sci. Signal. 10, eaak9982 (2017).
Li, J. et al. Nat. Methods 10, 1046–1047 (2013).
Ge, Z. et al. Cell Rep. 23, 213–226.e3 (2018).
Dinkel, H. et al. Nucleic Acids Res. 44, D294–D300 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Liang, H. Finding cancer drivers in the UPS system. Nat Cancer 1, 20–21 (2020). https://doi.org/10.1038/s43018-019-0013-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-019-0013-y
- Springer Nature America, Inc.
This article is cited by
-
PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration
Biology Direct (2023)